Standout Papers
- Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays (2010)
- Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study (2010)
- Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays (2014)
- Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays (2010)
- INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples (2004)
- More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate (2015)
- Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation (2004)
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Complement Factor H Polymorphism in Age-Related Macular Degeneration
2005 StandoutScience
The role of prothrombin complex concentrates in reversal of target specific anticoagulants
2014
The international normalized ratio according to Owren in liver disease: Interlaboratory assessment and determination of international sensitivity index
2013 StandoutNobel
Mechanisms of Thrombus Formation
2008 Standout
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
2011
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
2003
Molecular Bases for Circadian Clocks
1999 Standout
Intracerebral haemorrhage
2009 Standout
Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine
1992
Age-Related Macular Degeneration
2008 Standout
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013
2013
5 Thrombophilia: The Discovery of Activated Protein C Resistance
1995
A New Protein Conjugation System in Human
1998 StandoutNobel
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests
2016
Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
1993 Standout
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
2012
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins
2016 StandoutNobel
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery
2009
The role of the laboratory in treatment with new oral anticoagulants
2013
Management of anticoagulation with rivaroxaban in trauma and acute care surgery
2016
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
2014
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Osteoarthritis
2015 Standout
Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban
2013
Age-related macular degeneration
2012 Standout
Improving Site‐Directed RNA Editing In Vitro and in Cell Culture by Chemical Modification of the GuideRNA
2014
Subunits of Yeast RNA Polymerase II Transcription Factor TFIIH Encoded by the CCL1 Gene
1996 StandoutNobel
Direct Oral Anticoagulants in Emergency Trauma Admissions
2016
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Pre-eclampsia
2005 Standout
Oral Contraceptives and the Risk of Venous Thrombosis
2001
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
2011
Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
1997
A critical appraisal of point‐of‐care coagulation testing in critically ill patients
2015
Nopp 140 shuttles on tracks between nucleolus and cytoplasm
1992 StandoutNobel
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Pre-eclampsia
2010 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Survey of the year 2003 commercial optical biosensor literature
2004
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome
2001
Correlation of Coagulation Markers and 4F-PCC-Mediated Reversal of Rivaroxaban in a Rabbit Model of Acute Bleeding
2015
Recurrent miscarriage
2006 Standout
Thrombophilia in pregnancy: a systematic review
2005
Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography
2014
Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study
2001
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
2015
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis
2010
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1
2008
Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool
1998
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
1989
Prothrombin Gene G 20210 →A Transition Is a Risk Factor for Cerebral Venous Thrombosis
1998
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin
2011 StandoutNobel
Primary Prevention of Ischemic Stroke
2001
Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction
2003
Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms.
1993 StandoutNobel
Idarucizumab
2015
Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene
1998
An integral membrane protein of the pore membrane domain of the nuclear envelope contains a nucleoporin-like region
1993 StandoutNobel
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
Differential expression and regulation of multiple dynamins.
1994 StandoutNobel
Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool
1998
The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis.
1994 StandoutNobel
Prothrombin Mutation: Employing the Electrochemiluminescence Technology of the Elecsys® System for the Detection of the Point Mutation at Position 20210 in the 3’ Untranslated Region of the Prothrombin Gene
2001
Electrochemiluminescence (ECL)
2004 Standout
Effects of Clopidogrel and Aspirin in Combination Versus Aspirin Alone on Platelet Activation and Major Receptor Expression in Patients After Recent Ischemic Stroke
2005
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.
1997 StandoutNobel
An analysis of vertebrate mRNA sequences: intimations of translational control.
1991 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Primary Prevention of Ischemic Stroke
2001
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.
1993
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex
2003
Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
1995
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
2017
Innate Immune Recognition
2002 Standout
Venous thrombosis: a multicausal disease
1999 Standout
APC-resistance Is a Risk Factor for Postoperative Thromboembolism in Elective Replacement of the Hip or Knee – A Prospective Study
1999 StandoutNobel
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis.
2004
Protein S and C4b-Binding Protein: Components Involved in the Regulation of the Protein C Anticoagulant System
1991
Works of Andreas Hillarp being referenced
Molecular Analysis of the /5-Chain of Human C4B-Binding Protein
1991
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
2004 StandoutNobel
Protein S binding in relation to the subunit composition of human C4b‐binding protein
1989
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Genes for C4b-binding protein ?- and ?-chains (C4BPA andC4BPB) are located on chromosome 1, band 1q32, in humans and on chromosome 13 in rats
1990
Practical Viewpoints on the Diagnosis and Management of Heparin-Induced Thrombocytopenia
2011
A comparative in vitro evaluation of six von Willebrand factor concentrates
2004
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation
2004 StandoutNobel
Prospective Longitudinal Study of Thromboelastography and Standard Hemostatic Laboratory Tests in Healthy Women During Normal Pregnancy
2012
Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H
2003
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
2015 StandoutNobel
Resistance to activated protein C, the FV : Q 506 allele, and venous thrombosis
1996
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
2010 StandoutNobel
Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
2013
Thrombophilia as a multigenic disease.
1999
The protein S-binding site localized to the central core of C4b-binding protein.
1987
Assembly of protein S and C4b-binding protein on membranes.
1990
Diagnosing protein S deficiency: analytical considerations.
2003
[Coordinated Swedish transfer is recommended during 1999. Prothrombin complex measurement should be indicated as a quota, not percent].
1999 Nobel
Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?
2003
The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis
1997
Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.
1990
Geographic Distribution of the 20210 G to A Prothrombin Variant
1998
Analytical Considerations for Free Protein S Assays in Protein S Deficiency
2001
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
2001
Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.
1990
Bovine C4b binding protein. Molecular cloning of the alpha- and beta-chains provides structural background for lack of complex formation with protein S.
1994
Novel subunit in C4b-binding protein required for protein S binding.
1988